Chicago, IL— MDLifespan, a leader in therapeutic plasma exchange (TPE), is expanding its reach with new centers opening in Michigan, Florida, and Texas in 2025, and additional locations to follow nationwide.
The expansion introduces an innovative suite of PlasmaXchange Protocols, addressing critical areas such as brain health, heart health, immunity, anti-cancer prevention, baby wellness, and longevity.
Environmental toxins—microplastics, PFAS, heavy metals, and more—are now ubiquitous, infiltrating food, air, and water. Recent studies reveal that these toxins contribute significantly to chronic inflammation, oxidative damage, and diseases such as cancer, diabetes, and cardiovascular conditions.
According to toxin expert Dr. Paul Savage, founder of MDLifespan, “We are living in an era where toxin exposure has escalated dramatically, doubling every decade for the past 60 years. This cumulative burden blocks healing, accelerates aging, and fuels all chronic inflammatory diseases.”
MDLifespan’s PlasmaXchange Protocol represents a breakthrough in personalized medicine. Rooted in therapeutic plasma exchange (TPE), the protocol eliminates accumulated toxins, reduces chronic inflammation, and restores the body’s natural healing abilities. While TPE has been utilized in clinical settings for decades, MDLifespan reimagines its potential through proprietary processes designed to optimize health, healing and longevity.
Unlike traditional therapeutic plasma exchange, PlasmaXchange integrates personalized diagnostics, IV nutrient therapy, and advanced regenerative treatments, creating a holistic detoxification and health improvement approach. Often described as an “oil change for humans,” the process removes toxin-laden plasma and replaces it with natural albumin, restoring vitality at the cellular level.
MDLifespan’s revolutionary approach is rooted in three pillars: Data, Disease, and Detection. Using advanced diagnostics, PlasmaXchange measures toxin levels and tracks biomarker changes throughout the personalized treatment journey. This data-driven methodology provides clear, measurable evidence of progress and supports long-term health optimization.
“Our goal is to empower patients with actionable insights and transformative outcomes,” says Dr. Paul Savage, founder of MDLifespan. “By focusing on the removal of harmful toxins and tracking real-time health improvements, we’re setting a new standard in personalized medicine.”
Each PlasmaXchange protocol targets a specific aspect of health, offering tailored solutions backed by science:
Every protocol is supported by pre- and post-treatment laboratory testing to track measurable improvements, ensuring transparency and patient confidence.
MDLifespan’s expansion aligns with its mission as a Public Benefit Corporation to eliminate environmental toxins and enhance public health. This growth brings transformative health solutions closer to patients, particularly those in urban and suburban areas with a strong demand for premium wellness services.
Key stats on toxins and health risks underscore the urgency of MDLifespan’s mission:
With over 300 successful PlasmaXchange procedures performed to date, MDLifespan’s innovative therapies have significantly impacted patient wellness.
“This is more than a medical breakthrough; it’s a movement,” Dr. Savage states. “Our goal is to empower individuals to protect their health in an increasingly toxic world and discover what we can do with patients already beset by chronic inflammatory diseases.”
MDLifespan will celebrate its expansion with virtual and in-person events, offering consultations, webinars, and exclusive promotions to introduce the protocols to new communities.
About MDLifespan
MDLifespan combines decades of medical innovation with a commitment to creating a healthier, toxin-free future. As a Public Benefit Corporation, MDLifespan balances business success with measurable public benefits, delivering solutions that optimize health and vitality.